Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy.
Leuk Lymphoma. 2023 Jul-Aug;64(7):1355-1357. doi: 10.1080/10428194.2023.2199896. Epub 2023 Apr 12.
Leuk Lymphoma. 2023.
PMID: 37042674
No abstract available.
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia.
Berton G, Sedaki B, Collomb E, Benachour S, Loschi M, Mohty B, Saillard C, Hicheri Y, Rouzaud C, Maisano V, Villetard F, Corda ED', Charbonnier A, Rey J, Hospital MA, Ittel A, Abbou N, Fanciullino R, Dadone-Montaudié B, Vey N, Venton G, Cluzeau T, Alary AS, Garciaz S.
Berton G, et al.
Leuk Res. 2024 Jun;141:107500. doi: 10.1016/j.leukres.2024.107500. Epub 2024 Apr 15.
Leuk Res. 2024.
PMID: 38636413
Free article.
Item in Clipboard
Long-term survival of NPM1 AML treated with intensive chemotherapy with extensive molecular data available.
Garciaz S, Berton G, Hospital MA, Guille A, Adélaïde J, Saillard C, Hicheri Y, Mozziconacci MJ, Duprez E, Récher C, Alary AS, Birnbaum D, Vey N.
Garciaz S, et al. Among authors: berton g.
Leuk Lymphoma. 2024 May;65(5):700-703. doi: 10.1080/10428194.2024.2312430. Epub 2024 Feb 8.
Leuk Lymphoma. 2024.
PMID: 38329727
No abstract available.
Item in Clipboard
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
Bewersdorf JP, Shimony S, Shallis RM, Liu Y, Berton G, Schaefer EJ, Zeidan AM, Goldberg A, Stein E, Marcucci G, Bystrom RP, Lindsley RC, Chen EC, Ramos J, Stein A, Pullarkat V, Aldoss I, DeAngelo DJ, Neuberg DS, Stone RM, Garciaz S, Ball B, Stahl M.
Bewersdorf JP, et al. Among authors: berton g.
Am J Hematol. 2024 May 15. doi: 10.1002/ajh.27366. Online ahead of print.
Am J Hematol. 2024.
PMID: 38751104
No abstract available.
Item in Clipboard
Cite
Cite